Red blood cell distribution width and iron deficiency anemia among pregnant Sudanese women

  • Esam G Abdelrahman1,

    Affiliated with

    • Gasim I Gasim1, 3,

      Affiliated with

      • Imad R Musa1, 4,

        Affiliated with

        • Leana M Elbashir2, 4 and

          Affiliated with

          • Ishag Adam2, 4Email author

            Affiliated with

            Diagnostic Pathology20127:168

            DOI: 10.1186/1746-1596-7-168

            Received: 16 October 2012

            Accepted: 28 November 2012

            Published: 3 December 2012

            Abstract

            Background

            Iron deficiency anemia (IDA) is a major health problem during pregnancy and it has adverse effects on the mother and the newborn. Red cell distribution width (RDW), which is a quantitative measure for red cell size variation (anisocytosis), is a predictor of IDA. Little is known regarding RDW and IDA during pregnancy.

            Methods

            A cross sectional study was conducted at the antenatal clinic of Khartoum Hospital, Sudan, to determine the performance of RDW in the diagnosis of IDA using serum ferritin as a gold standard.

            Results

            Among 194 pregnant women with a gestational period of 21.4 ± 6.5 weeks, 57 (29.4%) had IDA according to serum ferritin levels (<15 μg/l) and 61 (31.4%) had IDA according to RDW (>14.5). The sensitivity, specificity, positive predictive value, and negative predictive value of RDW where serum ferritin was the gold standard were 43.8% (95% CI: 31.4–57.0%), 73.7% (95% CI: 65.8–80.5%), 41.0% (95% CI: 29.2–53.6%), and 76.0% (95% CI: 68.1–82.6%), respectively.

            Conclusions

            In this study, we found that RDW has a poor performance in diagnosing IDA among pregnant women compared with serum ferritin as the gold standard.

            Virtual slides

            The virtual slides for this article can be found here: http://​www.​diagnosticpathol​ogy.​diagnomx.​eu/​vs/​1721072967826303​

            Keywords

            Anemia Pregnancy Red cell distribution width Sudan

            Background

            It has been estimated that the highest proportions of individuals affected by anemia are in Africa, e.g. in neighboring Ethiopia, anemia is a major problem for both pregnant (62.7%) and non-pregnant (52.3%) women of child-bearing age [1]. However, the prevalence of anemia varies significantly both within and between countries, which indicates a need for local data to help improve preventive programs. Anemia during pregnancy is associated with increased maternal morbidity and mortality, and contributes to 20% of the maternal mortality in Africa [25]. Anemia is one of the most common nutritional deficiency disorders in the world [6]. The World Health Organization (WHO) defines iron deficiency anemia (IDA) as anemia accompanied by depleted iron stores and signs of a compromised supply of iron to the tissues [7, 8].

            Anemia during pregnancy is a large health problem in Sudan, where pregnant women in different regions of Sudan are more susceptible to anemia, irrespective of their age or parity [9, 10]. Furthermore, anemia is associated with poor maternal and perinatal outcomes, such as maternal and perinatal mortality [1012].

            Because of physiological changes that occur during pregnancy, some of the hematological parameters, such as mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC), are not sensitive indicators for diagnosing anemia/IDA because they are reduced only when anemia is severe or well established [13]. A peripheral blood film examination provides less information but it requires an expert’s opinion [14, 15], and anisocytosis is not sensitive in reflecting IDA because it is less prominent in pregnancy (Figure 1). During normal physiology in pregnancy, serum iron, serum ferritin, and its percentage saturation falls, and total iron binding capacity increases [1315]. Although serum ferritin is the gold standard for diagnosis of IDA, it is a complicated process, expensive, and being an acute phase reactant, may give misinterpretation because of false elevation [14]. Red cell distribution width (RDW) is a relatively new, routine parameter, which is evaluated in a fully automated hematology analyzer, and is part of the complete blood count (CBC). RDW can reflect early changes in RBCs, which are accompanied by IDA. Therefore, the CBC can be used as a simple and relatively cheap test to detect IDA through the e RDW [16]. RDW expresses small variations and changes in different populations of red cell size [17]. There are few published data on the performance of RDW and IDA during pregnancy [16]. Therefore, the current study was conducted to investigate the performance of RDW in diagnosing IDA in pregnancy, to thus provide information on anemia during pregnancy and its diagnostic tools in Sudan [18].
            http://static-content.springer.com/image/art%3A10.1186%2F1746-1596-7-168/MediaObjects/13000_2012_669_Fig1_HTML.jpg
            Figure 1

            Peripheral blood film with changes attributed to iron deficiency anemia.

            Methods

            A cross-sectional descriptive study was carried out at the antenatal clinic of Khartoum Hospital, Sudan during the period of January to March, 2012 to investigate the performance of RDW in diagnosing IDA where serum ferritin was the gold standard. A sample size of 190 subjects was calculated based on a 2-sided hypothesis tests using Epiinfo with 80% power and a confidence interval (CI) of 95%. After signing an informed consent, pregnant women attending the antenatal clinic for the first time with singletons were approached to participate in the study.

            Those subjects having any of the following: diabetes mellitus, hypertension, taking iron supplements or a history of blood transfusion within the last 3 months were excluded. The obstetric and medical history was determined using pretested questionnaires. A total of 5 ml of blood was collected through an aseptic venipuncture from the antecubital vein. Two milliliters of blood was taken in an ethylene diamine tetra acetic acid and immediately analyzed for a complete hemogram, including hemoglobin, white blood count (WBC), and RDW, using an automated hematology analyzer [19]. Details of the hemoanalyzer are provided in our previous study [18]. In summary, the Sysmex KX21N [19] is an automated blood cell counter intended for in vitro diagnostic use in clinical laboratories. It is a compact, fully automated hematology analyzer with simultaneous analysis of 18 parameters in whole blood mode and capillary blood mode. This analyzer counts blood cells as routine in a few minutes. The test was performed as stated in the manufacturer’s manual [19].

            The remaining 3 mls of blood were delivered into a dry clean plain container, centrifuged after clotting and kept at –20 °C until analysis for the serum iron profile. Ferritin levels were measured by immunofluorescent assay using Immulite kits (Siemens, Los Angeles, CA, USA).

            IDA was defined as hemoglobin less than 11 g/dl and serum ferritin level (<15 μg/l). Those women with severe anemia (hemoglobin <7 g/dl) and with leukocytosis (WBC >17.1 × 109/L were excluded. [20] RDW >14.5% is considered as abnormal and diagnostic for IDA [17]. The serum ferritin level (<15 μg/l) was the gold standard for the diagnosis of IDA in this study.

            Statistical analysis

            The sensitivity, specificity, positive predictive value, and negative predictive value were calculated. The sensitivity of the RDW was calculated as true positives/(true positive + false negatives), the specificity was calculated as true negatives/(true negatives + false positives), the positive predictive value was calculated as true positives/(true positives + false positives), and the negative predictive value was calculated as true negatives/(true negatives + false negatives) [21].

            Ethics

            The current study received ethical approval from the Department of Obstetrics in Khartoum Hospital, Sudan.

            Results

            During the study period, 212 pregnant women were initially enrolled and 194 fulfilled the inclusion criteria and their data are presented in this report. The characteristics of these women at admission to the study are shown in Table 1. Hemoglobin values ranged from 7.8–15.1 with a mean of 11.7 g/dl. Out of these 194 women, 57 (29.4%) and 61 (31.4%) had IDA according to serum ferritin and RDW cut-off levels for IDA.
            Table 1

            Basic characteristics of the pregnant women included in the study at Khartoum Teaching Hospital, Sudan

            Variables

            Mean (SD)

            Age, years

            25.6 (6.7)

            Parity

            1.79 (1.8)

            Gestational age, weeks

            21.4 (6.5)

            Weight, kg

            73.68 (16.6)

            Hemoglobin, gm/dl

            11.73 (1.2)

            Height/cm

            159.5 (6.8)

            Among the 57 women that had IDA using serum ferritin level as a diagnostic tool, 25 (43.8%) of them had IDA as indicated by RDW. Therefore, the sensitivity of RDW was 43.8% (95% CI: 31.4–57.0%). Among the 137 women who had no IDA using serum ferritin levels as a diagnostic tool, 36 had IDA by using RDW. The specificity of RDW was 73.7% (95% CI: 65.8–80.5%).

            Among those women who had IDA by RDW (61), 25 (41.0%) had IDA according to serum ferritin levels, while 36 did not have IDA. The positive predictive value of RDW was 41.0% (95% CI: 29.2–53.6%). Among those women who did not have IDA by RDW (133), 101 did not have IDA according to low serum ferritin levels, while 32 women had IDA. The negative predictive value of RDW was 76.0% (95% CI: 68.1–82.6%, Tables 2 and 3).
            Table 2

            Results of RDW compared with serum ferritin levels for diagnosis of IDA among pregnant women at Khartoum Hospital, Sudan

            IDA according to the serum ferritin result

            IDA according to RDW results

              

            IDA

            without IDA

            Total

             

            IDA

            25

            32

            57

             

            without IDA

            36

            101

            137

            Total

             

            61

            133

            194

            Table 3

            Performance of RDW in the diagnosis of IDA among pregnant women at Khartoum Hospital

            Validity test Percentage

            (95% CI)

            Sensitivity

            43.8 (31.4–57.0)

            Specificity

            73.7 (65.8–80.5)

            Positive predictive value

            41.0 (29.2–53.6)

            Negative predictive value

            76.0 (68.1–82.6)

            Discussion

            The main findings of the current study were the low sensitivity (43.8%) and moderate specificity (73.7%) of the RDW in the diagnosis of IDA among pregnant women in Sudan. Previously, hemoglobin was the most commonly used hematological parameter and screening test for IDA [22]. However, hemoglobin has its limitation in detecting IDA because sufficient time must elapse for iron to have an effect [23], and hemoglobin may take up to 2 months to show low levels [24]. A recent study showed that other hematological parameters, which can be estimated via a hemoanalyzer, such as MCV, MCH and MCHC, have poor performance in detecting IDA during pregnancy [16]. It is possible that these red cell indices (MCV, MCH and MCHC) are mean values, which cannot express the small variation of red cell size that occurs in early iron deficiency [25]. Changes in the peripheral blood film (e.g., erythrocyte hypochromia and microcytosis) are less prominent during pregnancy than during the non-pregnant condition, even in moderate iron deficiency [26]. Therefore, there is a need for a screening test that is cheap and has a high reliability and accuracy for identifying iron deficiency.

            A recent observation among non-pregnant women of child-bearing age showed that RDW (≥16.1%) had a sensitivity of 59.3% and specificity of 71% [27]. Another study among pregnant women in the first half of pregnancy (<20 weeks gestation) showed that an RDW ≥15 had a sensitivity and specificity of 46.8% and 95.7%, respectively [28]. A high sensitivity (82.3%) and specificity (97.4%) for RDW was reported recently among pregnant women [16]. Different rates of RDW have been reported. For example, Aulakh et al. [29] found that the sensitivity of RDW was 81.0% and the specificity was 53.4%, and vanZeben et al. [30] found that the sensitivity of RDW was 94% and the specificity was 59%.

            Some points need to be taken into consideration when comparing different studies. First, some reports used a ferritin level of 10 μg/l as a cut-off point for diagnosis of iron deficiency [3133]. Second, there was a difference in the gestational age between our study and previous studies [16, 28].

            It should be noted that because of the high prevalence of IDA in pregnancy, it is customary in many settings to consider/treat empirically pregnant anemic patients with iron supplements. Therefore, most of the studies, including the current study, were focused and designed to have maximum specificity for diagnosing IDA rather than achieving the most sensitivity.

            This study has some limitations. Hemoglobin electrophoresis, serum vitamin B12, and folate tests were not performed. Such tests are important for excluding hemoglobinopathies, early macrocytosis due to folic acid, or vitamin B12 deficiency where RDW may increase. Anemia of chronic disorders also could not be excluded by an appropriate investigation in cases where serum ferritin levels might have been misinterpreted. The other parameters of iron status or profile such as serum iron level, total iron binding capacity and transferrin saturation were not investigated. Screening for submicroscopic malaria (as it is one of the commonest causes of anaemia) was not performed.

            Conclusion

            In this study; RDW has a poorer performance than serum ferritin in diagnosing IDW among pregnant women.

            Declarations

            Acknowledgements

            We gratefully acknowledge the pregnant mothers who, despite their suffering, participated in this study. LME and IA were funded by the University of Khartoum, Sudan.

            Authors’ Affiliations

            (1)
            Khartoum Teaching Hospital
            (2)
            Faculty of Medicine, University of Khartoum
            (3)
            Faculty of Medicine, Qassim, University, Qassim
            (4)
            Buraidah Central Hospital

            References

            1. World Health Organization: Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system 1993 – information system 2005. Geneva: World Health Organization; Available at: http://​whqlibdoc.​who.​int/​publications/​2008/​9789241596657_​eng.​pdf
            2. Mohammed AA, Elnour MH, Mohammed EE, Ahmed SA, Abdelfattah AI: Maternal mortality in Kassala State - Eastern Sudan: community-based study using reproductive age mortality survey (RAMOS). BMC Pregnancy Childbirth 2011, 11:102.PubMedView Article
            3. Adam I, Elhassan EM, Haggaz AE, Ali AA, Adam GK: A: perspective of the epidemiology of malaria and anemia and their impact on maternal and perinatal outcomes in Sudan. J Infect Dev Ctries 2011,5(2):83–87.PubMedView Article
            4. De Benoist B, McLean E, Egli I, Cogswell M: Worldwide Prevalence of anemia 1993 2005: WHO Global Database on Anemia. Geneva: World Health Organization; 2008.
            5. Allen LH: Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin Nutr 2000, 71:1280S-1284S.PubMed
            6. Kalaivani K: Prevalence and consequences of anemia in pregnancy. Indian J Med Res 2009, 130:627–633.PubMed
            7. Osungbade KO, Oladunjoye AO: Preventive treatments of iron deficiency anemia in pregnancy: a review of their effectiveness and implications for health system strengthening. J Pregnancy 2012, 7:454601.
            8. World Health Organization: Iron deficiency anemia assessment prevention and control: a guide for program managers. Geneva, Switzerland: World Health Organization; 2001.
            9. Abdelgadir MA, Khalid AR, Ashmaig AL, Ibrahim AR, Ahmed AA, Adam I: Epidemiology of anemia among pregnant women in Geizera, central Sudan. J Obstet Gynaecol 2012, 32:42–44.PubMedView Article
            10. Ali AA, Rayis DA, Abdallah TM, Elbashir MI, Adam I: Severe anemia is associated with a higher risk for preeclampsia and poor perinatal outcomes in Kassala hospital, eastern Sudan. BMC Res Notes 2011,26(4):311.View Article
            11. Elhassan EM, Mirghani OA, Adam I: High maternal mortality and stillbirth in the Wad Medani Hospital, Central Sudan, 2003–2007. Trop Doct 2009,39(4):238–239.PubMedView Article
            12. Ali AA, Adam I: Anemia and stillbirth in Kassala Hospital, Eastern Sudan. J Trop Pediatr 2011, 57:62–64.PubMedView Article
            13. Rana S: Physiological changes and maternal adaptation to pregnancy, Obstetrics and perinatal care for developing countries. 5th edition. Pakistan: Pakistan Academy of Sciences Islamabad; 2002:172–186.
            14. Wenstrom KD, Leveno KJ: Maternal Adaptations to pregnancy, Williams obstetrics. 21st edition. New York: McGraw-Hill; 2001:167–170.
            15. Duffy TP: Hematologic aspects of pregnancy. In Medical complications during pregnancy. 5th edition. Edited by: Burrow GN, Duffy TP. India: W.B. Saunders; 2001:79–82.
            16. Sultana GS, Haque SA, Sultana T, Rahman Q, Ahmed ANN: Role of red cell distribution width (RDW) in the detection of iron deficiency anemia in pregnancy within the first 20 weeks of gestation. Bangladesh Med Res Counc Bull 2011, 37:102–105.PubMedView Article
            17. Bain BJ, Bates I: Basic haematological techniques. In Dacie and Lewis Practical Haematolog. 9th edition. Edited by: Lewis SM, Bain BJ, Bates I. London: Churchill livingstone Harcourt Publishers Ltd; 2001:19–45.
            18. Adam I, Ahmed S, Mahmoud MH, Yassin MI: Comparison of HemoCue hemoglobin-meter and automated hematology analyzer in measurement of hemoglobin levels in pregnant women at Khartoum hospital, Sudan. Diagn Pathol 2012,21(7):30.View Article
            19. Sysmex KX-21 N Operator’s Manual. Sysmex Corporation; 2006. http://​ebookbrowse.​com/​sysmex-kx-21-hematology-analyzer-instruction-manual-pdf-d326417196
            20. Nissl J: Complete blood count. Merit Care Health system [cited 2009 September 25]. 2006. Available from http://​www.​webmd.​com/​atozguides/​complete blood count CBC
            21. Harper R, Reeves B: Reporting of precision of estimates for diagnostic accuracy: a review. BMJ 1999, 318:1322–1323.PubMedView Article
            22. Khusun H, Yip R, Schultink W, Dillon DH: World Health Organization hemoglobin cut-off points for the detection of anemia are valid for an Indonesian population. J Nutr 1999, 129:1669–74.PubMed
            23. Clark SF: Iron Deficiency Anemia. Nutr Clin Pract 2008, 23:128–41.PubMedView Article
            24. Assessing iron status of populations: Report of a Joint World Health Organization/Centers for Disease Control and Prevention. Technical Consultation on the Assessment of iron Status at the Population Level. Geneva, Switzerland; Apr 6–8, 2004. [Online;retrieved on 2010 June 20]. Available from: http://​whqlibdoc.​who.​int/​publications/​2004/​9241593156_​eng.​pdf
            25. Viswanath D, Hegde R, Murthy V, Nagashree S, Shan R: Red cell distribution width in the diagnosis of iron deficiency anemia. Indian J Pediatr 2001,68(12):1117–19.PubMedView Article
            26. Cunningham FG, Gilstrap LC, Gant NF, Hauth JC, Wenstrom KD, Leveno KJ: Maternal Adaptations to pregnancy, Williams obstetrics. 21st edition. New York: McGraw-Hill; 2001:167–70.
            27. Alquaiz JM, Abdulghani HM, Khawaja RA, Shaffi-Ahamed S: Accuracy of various iron parameters in the prediction of iron deficiency anemia among healthy women of child bearing Age, Saudi Arabia. Iran Red Crescent Med J 2012, 14:397–401.PubMed
            28. Casanova B, Sammel MD, Macones GA: Development of a clinical prediction rule for iron deficiency anemia in pregnancy. Am J Obstet Gynecol 2005, 193:460–66.PubMedView Article
            29. Aulakh R, Sohi I, Singh T, Kakkar N: Red cell distribution width (RDW) in the diagnosis of iron deficiency with microcytic Hypochromic Anemia. Indian J Pediatr 2009, 76:265–67.PubMedView Article
            30. van Zeben D, Bieger R, ven Wermeskerken RKA, Castel A, Hermans J: Evaluation of microcytosis using serum ferritin and red blood cell distribution width. Eur J Haematol 1990, 44:105–8.
            31. Taylor DJ, Mallen C, McDougall N, Lind T: Effect of iron supplementation on serum ferritin levels during and after pregnancy. BJOG 1982, 89:1011–7.View Article
            32. Barrett JFR, Whittaker PG, Williams JG, Lind T: Absorption of non-haem iron from food during normal pregnancy. BMJ 1994, 309:79–82.PubMedView Article
            33. Byg KE, Milman N, Hansen S, Agger A: Serum ferritin is a reliable, non-invasive test for iron status in pregnancy: comparison of ferritin with other iron status markers in a longitudinal study on healthy pregnant women. Hematol 2000, 5:319–25.

            Copyright

            © Abdelrahman et al.; licensee BioMed Central Ltd. 2012

            This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

            Advertisement